Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH.

Like Comment

Non-alcoholic fatty liver disease (NAFLD) could play a catalyst role on the development of metabolic comorbidities, although the magnitude of this effect in metabolically healthy NAFLD patients remains unclear. We assessed the role of biopsy-proven NAFLD on the risk of developing type 2 diabetes mellitus (T2DM) and other metabolic comorbidities (arterial hypertension (AHT), and dyslipidemia) in metabolically healthy patients.From HEPAmet Registry (N=1030), we included 178 biopsy-proven NAFLD patients with a metabolically healthy status, defined by the absence of baseline T2DM, AHT, and dyslipidemia. Hepamet Fibrosis Score (HFS), NAFLD Fibrosis Score, and FIB-4 were calculated. Follow-up was computed from the biopsy to the diagnosis of T2DM, AHT, or dyslipidemia.During a follow-up of 5.6+4.4 years, T2DM occurred in 9% (16/178), AHT in 8.4% (15/178), low HDL in 9.6% (17/178), and hypertriglyceridemia in 23.6% (42/178) of patients. In multivariate analysis, significant fibrosis predicted T2DM and AHT. Independent variables related to T2DM appearance were significant fibrosis [HR 2.95 (CI95% 1.19-7.31); p=0.019], glucose levels [p=0.008], age [p=0.007] and BMI [p=0.039]. AHT was independently linked to significant fibrosis [HR 2.39 (CI95% 1.14-5.10); p=0.028], age [p=0.0001], BMI [p=0.006], glucose [p=0.021] and platelets [p=0.050]. The annual incidence rate of T2DM was higher in patients with significant fibrosis (4.4 vs. 1.2 cases per 100 person-years), and increased in presence of obesity, similar than AHT (4.6 vs. 1.1 cases per 100 person-years). HFS >0.12 predicted the risk of T2DM (25% (4/16) vs. HFS <0.12 4.5% (4/88); logRank 6.658, p=0.010).Metabolically healthy patients with NAFLD-related significant fibrosis were at higher risk for the development of T2DM and AHT. HFS>0.12, but not FIB4 or NFS predicted the occurrence of T2DM.



Click here to read the full article @ Journal of Hepatology
Go to the profile of ClinOwl

ClinOwl

The wider, wiser view for healthcare professionals. ClinOwl signposts the latest clinical content from over 100 leading medical journals.
2212 Contributions
1 Followers
0 Following

No comments yet.